Taking the Pressure Off Tonometry

• September 17, 2026

Perspectives on Medicare’s Proposed iDose TR Coverage Policy

In May 2026, 5 Medicare Administrative Contractors released proposed Local Coverage Determinations (LCDs) addressing Medicare reimbursement for anterior-segment intraocular nonbiodegradable drug-eluting systems, a category that currently includes only the travoprost intracameral implant iDose TR (Glaukos). Glaucoma Physician spoke with several leading surgeons who expressed concerns about the proposed LCDs and suggested changes they believe would better reflect contemporary glaucoma practice.

• by Steven R. Sarkisian, Jr., MD, Inder Paul Singh, MD, Savak “Sev” Teymoorian, MD, MBA, Manjool Shah, MD, Christine Funke, MD, Philip S. Garza, MD, MSc

• September 1, 2026

• 10 min

The Unmeasured Burden of Glaucoma: Part 2

How does one continue to live well when living with glaucoma-related vision impairment?

• by Kesh Patel

• September 16, 2026

• 7 min

Is There a Role for SLT After MIGS?

Is There a Role for SLT After MIGS? A practical framework for patient selection and clinical decision-making when intraocular pressure rises after minimally invasive glaucoma surgery.

• by Shivani S. Kamat, MD

• September 1, 2026

• 13 min